Andrew King
2021
In 2021, Andrew King earned a total compensation of $1.7M as Chief Scientific Officer at Aduro BioTech, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $160,657 |
|---|---|
| Option Awards | $873,842 |
| Salary | $393,333 |
| Stock Awards | $308,947 |
| Other | $2,500 |
| Total | $1,739,279 |
King received $873.8K in option awards, accounting for 50% of the total pay in 2021.
King also received $160.7K in non-equity incentive plan, $393.3K in salary, $308.9K in stock awards and $2.5K in other compensation.
Rankings
In 2021, Andrew King's compensation ranked 6,617th out of 12,415 executives tracked by ExecPay. In other words, King earned more than 46.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,617 out of 12,415 | 47th |
Division Manufacturing | 2,859 out of 5,508 | 48th |
Major group Chemicals And Allied Products | 1,258 out of 2,378 | 47th |
Industry group Drugs | 1,122 out of 2,099 | 47th |
Industry Pharmaceutical Preparations | 814 out of 1,549 | 47th |
Source: SEC filing on April 14, 2022.
King's colleagues
We found two more compensation records of executives who worked with Andrew King at Aduro BioTech in 2021.